Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03125811Phase 1Completed
Phase 1, randomised, open-label trial of Isopropyl alcohol in nausea ((none)) and Vomiting, sponsored by Texas Tech University Health Sciences Center. Primary endpoint: Change in Nausea Severity at 60 minutes. Started Jul 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03125811.